Repeat CT colonography may help detect more advanced right-sided lesions, but they detect fewer large polyps.
Fewer large polyps are detected with repeat CT colonography screening, although more advanced right-sided lesions are found, according to a study published in Radiology.
Researchers from the University of Wisconsin School of Medicine and Public Health in Madison sought to determine the rate and types of polyps detected at repeat CT colonography screening after initial negative findings at CT colonography screening.
The study included 5,640 patients with negative CT colonography screenings (no polyps ≥ 6 mm) performed before 2010 at one medical center. A total of 1,429 (25.3%; 736 women, 693 men) returned for repeat screenings. Their mean age was 61.4, mean interval between screenings was 5.7 years. The researchers compared the positive and histologic findings of initial and repeat screenings. For all patients with positive findings at repeat CT colonography, the findings were directly compared with the initial CT colonography findings.
The results showed that repeat CT colonography screenings were positive for lesions 6 mm or larger in 173 (12.1%) adults (compared with 14.3% at initial CT colonography screening). In the 173 patients, 29.5% (61 of 207) of nondiminutive polyps could be identified as diminutive at the initial CT colonography and 12.6% (26 of 207) were missed.
Other findings included:
The researchers concluded that positive rates for large polyps at repeat CT colonography screening were lower compared with those at initial screening, but more advanced right-sided lesions were detected at follow-up CT colonography, many of which were flat, serrated lesions. “The cumulative findings support both the nonreporting of diminutive lesions and a 5–10-year screening interval,” they wrote.
FDA Clears CT-Based AI Tools for PE Detection and Stroke Severity Assessment
March 26th 2024The artificial intelligence (AI) modalities CINA-iPE and CINA-ASPECTS may facilitate improved detection of incidental pulmonary embolism and stroke evaluation, respectively, based on computed tomography (CT) scans.
FDA Clears Remote Scanning Support Platform for MRI, CT and PET/CT
March 25th 2024The multimodality system nCommand Lite reportedly facilitates real-time remote imaging guidance on scanning parameters and procedure assessments to licensed technologists for a variety of imaging modalities including CT and MRI.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.